Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.57 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.57 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.57 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.57 |
| ▸ | DUT | P33316 | 1/20 | 0.49 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.44 |
| ▸ | P2RY2 | P41231 | 10/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 6/20 | 0.43 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8642265 | 1.00 | SLC28A1 (0.57) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL991867 | 0.95 | SLC28A1 (0.54) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL15294575 | 0.95 | SLC28A1 (0.54) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL25402577 | 0.95 | SLC28A1 (0.54) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL24487861 | 0.95 | SLC28A1 (0.54) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL991866 | 0.95 | SLC28A1 (0.54) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL10195335 | 0.95 | SLC28A1 (0.54) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL24782038 | 0.91 | SLC28A1 (0.55) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL733979 | 0.91 | SLC28A1 (0.64) | SLC28A1SLC28A2SLC29A1SLC28A3DUT | |
| SCHEMBL21625668 | 0.91 | SLC28A1 (0.64) | SLC28A1SLC28A2SLC29A1SLC28A3DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220290145-A1 | Modified RNA Agents with Reduced Off-Target Effect | ALNYLAM PHARMACEUTICALS, INC. (US) | 2022-09-15 | — | — | US | disclosed |
| US-20210238595-A1 | MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT | ALNYLAM PHARMACEUTICALS, INC. (US) | 2021-08-05 | — | — | US | disclosed |